•FDA has been conducting inspections of
compounding pharmacies for cause (in response to serious adverse event reports,
reports of quality problems, and state requests)
•FDA has also been conducting proactive
inspections to identify pharmacies with deficient sterile practices
•FDA will continue these efforts as
available resources permit
quoted from - Compounding Pharmacies - Erika Butler, Drug Specialist, U.S. Food and Drug Administration
1 comment:
You've posted a very informative post here about Drug Safety Monitoring Services. This article provided me with some useful knowledge. Thank you for sharing that. Keep up the good work.
Post a Comment